Each year more than 600,000 people die from more than 100 types and subtypes of cancer. Only four of these types (lung, breast, colorectal and cervical) have approved screening tests. Current research is working on two MCDE tests that will each be able to detect the other types of cancer. The following tests are in the most advanced stage of development.
The Galleri test: is most fully developed. The FDA has granted it "breakthrough device:" status, which allows it to be sold upon a prescription by your physician. Further development is taking place. Multiple clinical trials are being conducted on this test. NOTE: At this time, it should not be considered a replacement for standard screening tests, if such are available.
The Cancer Guard test: Is not yet, at the time the basic article was written, approved by the FDA.
The One Test: is programmed to detect a much smaller number of cancers. It can also be obtained by your physician, at a much smaller cost.
* * * * * * * * * * * *
The information stated above is not intended to provide medical advice either to any person, or for any clinical condition. Such information should only be obtained from a licensed clinical provider, which I am not.
My comments above are largely based on an article written by Nima Nabavizadeh, and published in the June 1, 2023 edition of Bottom Line Personal. The title of her article was: "Big Breakthrough In Cancer Detection: The Multi-Cancer Early Detection Test. That article should be referenced as my comments are brief and do not cover the subject as fully as the article does. In addition, as this article was published a year ago, updated information should be obtained from your licensed clinical provider.